Published in J Am Coll Cardiol on April 23, 2013
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis (2014) 1.53
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int (2015) 1.03
Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study. J Am Heart Assoc (2014) 0.89
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study. Hypertension (2015) 0.87
Risk stratification of resistant hypertension in chronic kidney disease. J Am Coll Cardiol (2013) 0.86
Resistant hypertension in nondialysis chronic kidney disease. Int J Hypertens (2013) 0.86
Health-related quality of life in persons with apparent treatment-resistant hypertension on at least four antihypertensives. J Hum Hypertens (2015) 0.80
Recognition and Management of Resistant Hypertension. Clin J Am Soc Nephrol (2016) 0.80
Lifestyle modification for resistant hypertension: The TRIUMPH randomized clinical trial. Am Heart J (2015) 0.78
The autonomic nervous system and renal physiology. Int J Nephrol Renovasc Dis (2013) 0.77
Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension. J Am Soc Hypertens (2016) 0.77
Resistant hypertension, patient characteristics, and risk of stroke. PLoS One (2014) 0.77
Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort Study. Am J Nephrol (2016) 0.75
Effect of Islam-based religious program on spiritual wellbeing in elderly with hypertension. Iran J Nurs Midwifery Res (2017) 0.75
The relationships of sleep apnea, hypertension, and resistant hypertension on chronic kidney disease. Medicine (Baltimore) (2016) 0.75
Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study. BMC Nephrol (2016) 0.75
Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women's Heart Disease. J Womens Health (Larchmt) (2016) 0.75
Hypertension: Resistant hypertension matters in chronic kidney disease. Nat Rev Nephrol (2013) 0.75
Baseline Antihypertensive Drug Count and Patient Response to Hypertension Medication Management. J Clin Hypertens (Greenwich) (2015) 0.75
Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus. J Am Heart Assoc (2017) 0.75
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet (2010) 7.69
Fruit, vegetables, and olive oil and risk of coronary heart disease in Italian women: the EPICOR Study. Am J Clin Nutr (2010) 5.50
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA (2012) 5.27
Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis (2007) 3.79
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension (2008) 2.99
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J (2012) 2.42
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials. Lancet Oncol (2005) 2.36
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. J Clin Oncol (2009) 2.30
Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial. Am J Kidney Dis (2013) 2.27
Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care (2012) 2.21
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cancer (2005) 2.15
Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study. BJU Int (2013) 2.08
Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study. Catheter Cardiovasc Interv (2002) 2.07
Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med (2011) 2.06
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol (2005) 1.88
Relative plasma volume monitoring during hemodialysis AIDS the assessment of dry weight. Hypertension (2009) 1.87
Dietary glycemic load and index and risk of coronary heart disease in a large italian cohort: the EPICOR study. Arch Intern Med (2010) 1.77
Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol (2007) 1.76
Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle (2010) 1.73
Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression. Am J Kidney Dis (2008) 1.71
Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial. J Clin Oncol (2009) 1.71
A longitudinal study of kidney structure and function in adults. Nephrol Dial Transplant (2009) 1.63
NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension? Eur Urol (2006) 1.59
Pro: Thresholds to define chronic kidney disease should not be age-dependent. Nephrol Dial Transplant (2014) 1.57
Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients. Nephrol Dial Transplant (2012) 1.53
A systematic evaluation of bioelectrical impedance measurement after hemodialysis session. Kidney Int (2004) 1.53
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol (2012) 1.43
Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: findings from 12 Italian population samples. Am J Epidemiol (2006) 1.43
A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. Kidney Int (2003) 1.40
Trended cosinor change model for analyzing hemodynamic rhythm patterns in hemodialysis patients. Hypertension (2007) 1.39
Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis (2007) 1.38
Newly developed techniques to study and diagnose acute renal failure. J Am Soc Nephrol (2003) 1.38
A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis (2006) 1.38
Analyzing change: a primer on multilevel models with applications to nephrology. Am J Nephrol (2008) 1.36
Home blood pressure monitoring in CKD. Am J Kidney Dis (2005) 1.34
Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Care (2011) 1.26
Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol (2009) 1.26
Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON). Am J Nephrol (2013) 1.23
Pulmonary hypertension in CKD. Am J Kidney Dis (2012) 1.19
Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE. Eur J Cardiovasc Prev Rehabil (2006) 1.15
Assessment of blood pressure in hemodialysis patients. Semin Dial (2002) 1.15
Wellens syndrome: a life-saving diagnosis. Am J Emerg Med (2010) 1.15
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int (2002) 1.15
Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine (2013) 1.15
Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy. Am J Kidney Dis (2008) 1.12
Hyporesponsiveness to erythropoietin: causes and management. Adv Chronic Kidney Dis (2009) 1.12
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Kidney Int (2003) 1.11
Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: a systematic review. Diabetes Res Clin Pract (2010) 1.10
Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer. J Clin Oncol (2007) 1.10
Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status. Semin Dial (2009) 1.10
Statin induced proteinuria: renal injury or renoprotection? J Am Soc Nephrol (2004) 1.09
Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation. Am J Physiol Endocrinol Metab (2010) 1.09
Altered water renal handling in patients with HIV infection. J Nephrol (2013) 1.08
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis (2013) 1.08
A priori-defined dietary patterns are associated with reduced risk of stroke in a large Italian cohort. J Nutr (2011) 1.08
Letter to the Editor: comment on the article "estimating the influence of physicians on the underuse of drugs in diabetic nephropathy in Taiwan" by Huang et al, and author's reply. J Nephrol (2013) 1.07
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials. Eur J Cancer (2010) 1.06
Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause (2013) 1.06
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. Kidney Int (2013) 1.05
Early changes in bioelectrical estimates of body composition in chronic kidney disease. J Am Soc Nephrol (2006) 1.04
Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies. Endocrine (2014) 1.04
Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clin J Am Soc Nephrol (2011) 1.04
Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review. J Diabetes Complications (2011) 1.02
Chronic kidney disease as a coronary disease equivalent--a comparison with diabetes over a decade. Clin J Am Soc Nephrol (2011) 1.02
Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: one center's experience and review of the literature. Int Urol Nephrol (2003) 1.02
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. Nephrol Dial Transplant (2011) 1.01
Metabolic syndrome and endometrial cancer: a meta-analysis. Endocrine (2013) 1.00
New therapies from old medicines. Nat Biotechnol (2008) 0.99
Pulse wave velocity is associated with muscle mass decline: Health ABC study. Age (Dordr) (2011) 0.99
Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer. Lung Cancer (2012) 0.99
Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrol Dial Transplant (2007) 0.98
Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality. Clin J Am Soc Nephrol (2009) 0.97
Peridialytic, intradialytic, and interdialytic blood pressure measurement in hemodialysis patients. Am J Kidney Dis (2009) 0.97
Early diabetes as a model for testing the regulation of juxtaglomerular NOS I. Am J Physiol Renal Physiol (2004) 0.96
Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large Italian cohort. J Nutr (2010) 0.96
Acute injury with intravenous iron and concerns regarding long-term safety. Clin J Am Soc Nephrol (2006) 0.96
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. Kidney Int (2012) 0.95
Development and validation of bioimpedance analysis prediction equations for dry weight in hemodialysis patients. Clin J Am Soc Nephrol (2007) 0.95